236
Views
30
CrossRef citations to date
0
Altmetric
Research Articles

Some Considerations for Excess Zeroes in Substance Abuse Research

, Ph.D., , Ph.D., , M.S.P.H., Ph.D. & , M.D., Ph.D.
Pages 376-382 | Published online: 22 Aug 2011
 

Abstract

Background: Count data collected in substance abuse research often come with an excess of “zeroes,” which are typically handled using zero-inflated regression models. However, there is a need to consider the design aspects of those studies before using such a statistical model to ascertain the sources of zeroes. Objectives: We sought to illustrate hurdle models as alternatives to zero-inflated models to validate a two-stage decision-making process in situations of “excess zeroes.” Methods: We use data from a study of 45 cocaine-dependent subjects where the primary scientific question was to evaluate whether study participation influences drug-seeking behavior. The outcome, “the frequency (count) of cocaine use days per week,” is bounded (ranging from 0 to 7). We fit and compare binomial, Poisson, negative binomial, and the hurdle version of these models to study the effect of gender, age, time, and study participation on cocaine use. Results: The hurdle binomial model provides the best fit. Gender and time are not predictive of use. Higher odds of use versus no use are associated with age; however once use is experienced, odds of further use decrease with increase in age. Participation was associated with higher odds of no-cocaine use; once there is use, participation reduced the odds of further use. Conclusion: Age and study participation are significantly predictive of cocaine-use behavior. Scientific Significance: The two-stage decision process as modeled by a hurdle binomial model (appropriate for bounded count data with excess zeroes) provides interesting insights into the study of covariate effects on count responses of substance use, when all enrolled subjects are believed to be “at-risk” of use.

ACKNOWLEDGEMENTS

This study was supported by grant 5U10-DA013727, “South Carolina Consortium of the Clinical Trials Network,” from the NIH/NIDA. Bandyopadhyay acknowledges support from grant P32-RR017696 from NIH/NCRR. We thank Amy Wahlquist for her assistance in creating plots.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.